|The IgA2, kappa n/a (Catalog #MBS318212) is an Antibody produced from Human Myeloma Plasma and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s IgA2, kappa can be used in a range of immunoassay formats including, but not limited to, IEP. Researchers should empirically determine the suitability of the IgA2, kappa n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Inactivation: Not applicable. Buffer: 10mM Phosphate buffer, pH 7.4 containing 150mM Sodium chloride
Preservative: 0.05% Sodium azide
Warnings: This product contains sodium azide, which has been classified as Xn (Harmful), in European Directive 67/548/EEC in the concentration range of 0.1 - 1.0 %. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains.
All human source material have tested negative for HIV1 and HIV2 and non-reactive for HCV and HBc antibodies and HBsAf by FDA required tests. No test guarantees a product to be non-infectious. Therefore, all material derived from human fluids or tissues should be considered as potentially infectious. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing IgA2, kappa are readily searchable from our website. Different antibodies against the same target such as IgA2, kappa may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.